Cargando…
Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells
Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, are used to reduce cholesterol biosynthesis in the liver. Accordingly, statins regulate nitric oxide (NO) and glutamate metabolism, inflammation, angiogenesis, immunity and endothelial progenitor cells (EPCs) functions...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550447/ https://www.ncbi.nlm.nih.gov/pubmed/26309120 http://dx.doi.org/10.1371/journal.pone.0136405 |
_version_ | 1782387460211212288 |
---|---|
author | Chiang, Kuang-Hsing Cheng, Wan-Li Shih, Chun-Ming Lin, Yi-Wen Tsao, Nai-Wen Kao, Yung-Ta Lin, Chih-Ting Wu, Shinn-Chih Huang, Chun-Yao Lin, Feng-Yen |
author_facet | Chiang, Kuang-Hsing Cheng, Wan-Li Shih, Chun-Ming Lin, Yi-Wen Tsao, Nai-Wen Kao, Yung-Ta Lin, Chih-Ting Wu, Shinn-Chih Huang, Chun-Yao Lin, Feng-Yen |
author_sort | Chiang, Kuang-Hsing |
collection | PubMed |
description | Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, are used to reduce cholesterol biosynthesis in the liver. Accordingly, statins regulate nitric oxide (NO) and glutamate metabolism, inflammation, angiogenesis, immunity and endothelial progenitor cells (EPCs) functions. The function of EPCs are regulated by stromal cell-derived factor 1 (SDF-1), vascular endothelial growth factor (VEGF), and transforming growth factor β (TGF-β), etc. Even though the pharmacologic mechanisms by which statins affect the neovasculogenesis of circulating EPCs, it is still unknown whether statins affect the EPCs function through the regulation of CXCR4, a SDF-1 receptor expression. Therefore, we desired to explore the effects of statins on CXCR4 expression in EPC-mediated neovascularization by in vitro and in vivo analyses. In animal studies, we analyzed the effects of atorvastatin or rosuvastatin treatments in recovery of capillary density and blood flow, the expression of vWF and CXCR4 at ischemia sites in hindlimb ischemia ICR mice. Additionally, we analyzed whether the atorvastatin or rosuvastatin treatments increased the mobilization, homing, and CXCR4 expression of EPCs in hindlimb ischemia ICR mice that underwent bone marrow transplantation. The results indicated that statins treatment led to significantly more CXCR4-positive endothelial progenitor cells incorporated into ischemic sites and in the blood compared with control mice. In vivo, we isolated human EPCs and analyzed the effect of statins treatment on the vasculogenic ability of EPCs and the expression of CXCR4. Compared with the control groups, the neovascularization ability of EPCs was significantly improved in the atorvastatin or rosuvastatin group; this improvement was dependent on CXCR4 up-regulation. The efficacy of statins on improving EPC neovascularization was related to the SDF-1α/CXCR4 axis and might be regulated by the NO. In conclusion, atorvastatin and rosuvastatin improved neovascularization in hindlimb ischemia mice; this effect may have been mediated by increased CXCR4 expression in EPCs. |
format | Online Article Text |
id | pubmed-4550447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45504472015-09-01 Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells Chiang, Kuang-Hsing Cheng, Wan-Li Shih, Chun-Ming Lin, Yi-Wen Tsao, Nai-Wen Kao, Yung-Ta Lin, Chih-Ting Wu, Shinn-Chih Huang, Chun-Yao Lin, Feng-Yen PLoS One Research Article Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, are used to reduce cholesterol biosynthesis in the liver. Accordingly, statins regulate nitric oxide (NO) and glutamate metabolism, inflammation, angiogenesis, immunity and endothelial progenitor cells (EPCs) functions. The function of EPCs are regulated by stromal cell-derived factor 1 (SDF-1), vascular endothelial growth factor (VEGF), and transforming growth factor β (TGF-β), etc. Even though the pharmacologic mechanisms by which statins affect the neovasculogenesis of circulating EPCs, it is still unknown whether statins affect the EPCs function through the regulation of CXCR4, a SDF-1 receptor expression. Therefore, we desired to explore the effects of statins on CXCR4 expression in EPC-mediated neovascularization by in vitro and in vivo analyses. In animal studies, we analyzed the effects of atorvastatin or rosuvastatin treatments in recovery of capillary density and blood flow, the expression of vWF and CXCR4 at ischemia sites in hindlimb ischemia ICR mice. Additionally, we analyzed whether the atorvastatin or rosuvastatin treatments increased the mobilization, homing, and CXCR4 expression of EPCs in hindlimb ischemia ICR mice that underwent bone marrow transplantation. The results indicated that statins treatment led to significantly more CXCR4-positive endothelial progenitor cells incorporated into ischemic sites and in the blood compared with control mice. In vivo, we isolated human EPCs and analyzed the effect of statins treatment on the vasculogenic ability of EPCs and the expression of CXCR4. Compared with the control groups, the neovascularization ability of EPCs was significantly improved in the atorvastatin or rosuvastatin group; this improvement was dependent on CXCR4 up-regulation. The efficacy of statins on improving EPC neovascularization was related to the SDF-1α/CXCR4 axis and might be regulated by the NO. In conclusion, atorvastatin and rosuvastatin improved neovascularization in hindlimb ischemia mice; this effect may have been mediated by increased CXCR4 expression in EPCs. Public Library of Science 2015-08-26 /pmc/articles/PMC4550447/ /pubmed/26309120 http://dx.doi.org/10.1371/journal.pone.0136405 Text en © 2015 Chiang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Chiang, Kuang-Hsing Cheng, Wan-Li Shih, Chun-Ming Lin, Yi-Wen Tsao, Nai-Wen Kao, Yung-Ta Lin, Chih-Ting Wu, Shinn-Chih Huang, Chun-Yao Lin, Feng-Yen Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells |
title | Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells |
title_full | Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells |
title_fullStr | Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells |
title_full_unstemmed | Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells |
title_short | Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells |
title_sort | statins, hmg-coa reductase inhibitors, improve neovascularization by increasing the expression density of cxcr4 in endothelial progenitor cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550447/ https://www.ncbi.nlm.nih.gov/pubmed/26309120 http://dx.doi.org/10.1371/journal.pone.0136405 |
work_keys_str_mv | AT chiangkuanghsing statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT chengwanli statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT shihchunming statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT linyiwen statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT tsaonaiwen statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT kaoyungta statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT linchihting statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT wushinnchih statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT huangchunyao statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells AT linfengyen statinshmgcoareductaseinhibitorsimproveneovascularizationbyincreasingtheexpressiondensityofcxcr4inendothelialprogenitorcells |